Childhood Neuroblastic Tumor

subtype

Identifier: CI-CAN-00002297
Entity page: /cancer/childhood-neuroblastic-tumor ↗
Edges: 14

Neighbours: 10 drugs4 trials
Drawn: 14 of 14 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Childhood Neuroblastic Tumor investigated in trials for …INVESTIGATED_IN_TRIALSderived10 of 10
→ investigated in trials for	Cyclophosphamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Childhood Neuroblastic Tumor	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants

Childhood Neuroblastic Tumor studied in …STUDIED_INderived4 of 4
→ studied in	NCT07819838Phase 1/Phase 2 · not yet recruiting Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations · condition mapped CURATED_BROADER · 4 trials mapped (3 active)	—	—	Childhood Neuroblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06674811recruiting Biomarkers of Resiliency In Childhood Cancer Surgery · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Childhood Neuroblastic Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT06528496Phase 2 · recruiting N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Childhood Neuroblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04539366Phase 1 · suspended Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial · condition mapped CURATED_BROADER · 4 trials mapped (3 active)	—	—	Childhood Neuroblastoma	1	Observed	clinicaltrials	graph →

Childhood Neuroblastic Tumor studied in …STUDIED_INderived4 of 4

→ studied in

NCT07819838Phase 1/Phase 2 · not yet recruiting

Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations · condition mapped CURATED_BROADER · 4 trials mapped (3 active)

—

Childhood Neuroblastoma

Observed

clinicaltrials

graph →

→ studied in

NCT06674811recruiting

Biomarkers of Resiliency In Childhood Cancer Surgery · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Childhood Neuroblastic Tumor

Observed

clinicaltrials

graph →

→ studied in

NCT06528496Phase 2 · recruiting

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Childhood Neuroblastoma

Observed

clinicaltrials

graph →

→ studied in

NCT04539366Phase 1 · suspended

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial · condition mapped CURATED_BROADER · 4 trials mapped (3 active)

—

Childhood Neuroblastoma

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains